A breast cancer survivor treated with doxorubicin 5 years ago presents with dyspnea on exertion and reduced ejection fraction. Which screening tool is most appropriate for ongoing cardiac surveillance?
-
A
Annual ECG only
-
B
Echocardiogram every 1-2 years
-
C
Stress test every 6 months
-
D
Serum troponin level annually